VEGFD and systemic sclerosis: Exploring the distribution in the SSc-PAH subgroup, compared with SSc-noPH, the same factors remain significantly up- or downregulated, except for VEGFD, which shows no statistically significant elevation in SSc-PAH alone (data not shown).